Genomic-Based Early Detection Screening: A Literature Review of Prospective Trials and Emerging Strategies for Gastrointestinal Cancers.

Numerous genomic-based early detection screening tests are being developed. These tests have the potential to revolutionize current single-organ screening paradigms, especially in gastrointestinal cancers. In this review, we underscore the performance of these genomic-based early detection tests based on prospective clinical trials. Moreover, we discuss a professional advancement for gastroenterologists in the diagnostic assessment of individuals who are cancer signal positive.
Competing Interests: Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: Nima Nabavizadeh declare(s) personal fees from GRAIL. Dr. Nabavizadeh played a role in consulting and advisory. . Nima Nabavizadeh declare(s) personal fees from Freenome. Dr. Nabavizadeh played a role in consulting and advisory. . Nima Nabavizadeh declare(s) personal fees from Pharmacy Times. Dr. Nabavizadeh played a role in consulting and advisory. . Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
(Copyright © 2024, Tizpa et al.)